CNBCA
CNBCA is a potent, selective, competitive SHP2 enzyme inhibitor, with the IC50 of 0.87 μM. CNBCA binds to full-length SHP2 and inhibits enzyme activity. CNBCA inhibits pAkt and pERK1/2, and the cell growth of BT474 and MDA-MB468 cells. CNBCA can be used for breast cancer study.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3044817-00-4
- Fòrmula: C26H34O5
- Peso molecular:426.55
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
0.87 μM (SHP2)[1]
CNBCA (0.25, 0.50, 1, 2 μM, 48 h) inhibits SHP2 mediated Akt and ERK1/2 activation in the BT474 and MDA-MB468 cells with an approximate IC50 of 1.0 μM[1].
CNBCA (500 nM, 24-72 h) inhibits cell growth in the BT474 and MDA-MB468 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:BT474 and MDA-MB468 cells
-
Concentration:0.25, 0.50, 1, 2 μM
-
Incubation Time:48 h
-
Result:Inhibited SHP2 mediated Akt and ERK1/2 activation.
Chemical Information
-
No. CAS 3044817-00-4
-
Peso molecular 426.55
-
Fòrmula C26H34O5
-
SMILES
OC(CCCC1=C(OCCCCCCCCC)C=CC(C2=CC=C(C(O)=O)C=C2)=C1)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)